Selectis Health (GBCS) Net Margin (2010 - 2025)

Selectis Health has disclosed Net Margin across 12 years of filings, most recently posting 8.39% for Q4 2025.

• Net Margin for Q4 2025 came in at 8.39%, down 285.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 2.54% (up 365.0% YoY), and the FY2025 annual result was 2.54%, up 365.0% from the prior year.
• Net Margin came in at 8.39% for Q4 2025 at Selectis Health, down from 6.87% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 41.83% in Q1 2023 to a low of 39.56% in Q4 2023.
• The 5-year median for Net Margin is 7.39% (2025), against an average of 6.34%.
• Across the five-year window, Net Margin soared 3956 bps in 2023 and slumped 5281 bps in 2024, its largest moves.
• Selectis Health's Net Margin stood at 17.64% in 2021, then slipped by 15 bps to 20.37% in 2022, then slumped by 94 bps to 39.56% in 2023, then soared by 86 bps to 5.54% in 2024, then plunged by 51 bps to 8.39% in 2025.
• The last three Net Margin figures came in at 8.39% (Q4 2025), 6.87% (Q3 2025), and 3.02% (Q2 2025), per Business Quant data.